SMAD4 and leukemia: Therefore, tyrosine phosphorylation of Smad4 at Y195/Y301/Y322 sites by ABL1 renders Smad4 dysfunctional and consequently blocks expression of CDK inhibitors and other growth regulators that are strictly controlled by TGF-β signaling, thus contributing to uncontrolled proliferation of leukemia cells.